Copyright: ©Author(s) 2026.
World J Gastroenterol. May 21, 2026; 32(19): 115332
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.115332
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.115332
Figure 5 DDIT3 restored the phenotype mediated by PRMT5 or HLCL-61.
A and B: The protein levels of PRMT5 and DDIT3 were examined by western blot; C and D: DDIT3 rescued the growth of hepatocellular carcinoma (HCC) cells mediated by PRMT5; E and F: DDIT3 restored the clone formation of HCC cells mediated by PRMT5; G and H: Down-regulation of DDIT3 reduced the cell apoptosis of HCC cells induced by knocking down PRMT5 expression. Data are presented as the mean ± SD. aP < 0.05. bP < 0.01. cP < 0.001. NS: Not significant; Scr: Scramble; OD: Optical density; FITC: Fluorescein isothiocyanate; PI: Propidium iodide; shPRMT5: Short hairpin RNA of PRMT5; shDDIT3: Short hairpin RNA of DDIT3.
- Citation: Jiang H, Yan JH, Tang WJ, Shen B, Mo S, Wang Y, Hu DH, Dong ZX, Zhang SB. PRMT5 imposed a dual repression on DDIT3 transcription to promote the malignancy of hepatocellular carcinoma. World J Gastroenterol 2026; 32(19): 115332
- URL: https://www.wjgnet.com/1007-9327/full/v32/i19/115332.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i19.115332